Filing Details
- Accession Number:
- 0001209191-20-045930
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-10 16:13:55
- Reporting Period:
- 2020-08-06
- Accepted Time:
- 2020-08-10 16:13:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 1,223 shares | Avg. Price: $271.19 | Total Value: $331,662.77 |
| Number of Shares After Transactions: | 28,902 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-06 | 1,223 | $155.57 | 30,125 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-06 | 490 | $270.12 | 29,635 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-06 | 423 | $271.39 | 29,212 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-06 | 310 | $272.60 | 28,902 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-06 | 1,223 | $0.00 | 1,223 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,338 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $270.12 (range $269.73 to $270.58).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $271.39 (range $270.94 to $271.89).
- Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.35 to $272.88).
- The option vests in 16 quarterly installments from 02/06/2018.
Billionaire Hedge Funds
